Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Asymmetric Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112479948A details a novel NHC-catalyzed asymmetric Michael addition for beta-sulfonyl chiral amines, offering metal-free synthesis and high enantioselectivity for pharmaceutical intermediates.
Patent CN110317201B reveals a high-yield asymmetric route for Moxifloxacin intermediates. Discover cost-effective manufacturing and supply chain advantages.
Discover advanced iridium-catalyzed synthesis for chiral bisallyl compounds with three consecutive chiral centers. Enhance supply chain reliability and reduce manufacturing costs.
Patent CN102040625B discloses efficient chiral spiro ligands for iridium-catalyzed asymmetric hydrogenation, offering high enantioselectivity and low catalyst loading for pharmaceutical manufacturing.
Discover the advanced enantioselective process for HMG-CoA inhibitors described in CN1636004A. Achieve high purity statin intermediates with reduced waste and scalable catalytic methods.
Novel asymmetric [3+2] cyclization method for high-purity chiral five-membered thiaheterocyclic nucleoside analogues with superior enantioselectivity and scalable yield.
Patent CN107384982A reveals enzymatic route for Evogliptin. Offers high purity and scalable manufacturing for global pharmaceutical supply chains.
Novel chiral epoxy propyl benzo-heterocycle synthesis for ROMK inhibitors. High ee, scalable route for pharmaceutical intermediates supply.
Patent CN115093313A discloses high-enantioselectivity rhodium catalysts for C-H activation, offering scalable routes for pharmaceutical intermediates.
Patent CN101090770B discloses a dual-ligand Rh-catalyzed system for asymmetric hydrogenation, delivering superior enantioselectivity and cost efficiency for API manufacturing.
Novel asymmetric SN1 alkylation patent CN120172863A enables mild condition synthesis. Reliable indene derivative supplier offering cost reduction and scalable production for global pharma.
Novel chiral palladium catalysts for asymmetric synthesis offering high stability and selectivity for pharmaceutical intermediate manufacturing and cost reduction.
Patent CN102827030A details a safe, high-yield route for (3R,5R)-3,5-dihydroxy-6-cyanohexanoate, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN116102406B introduces tunable biphenol ligands enhancing enantioselectivity. Offers cost reduction and supply reliability for pharmaceutical intermediate manufacturing processes.
Patent CN1968927B details a novel Ru-catalyzed route for high-purity quinoline intermediates used in bronchodilators, offering significant cost reduction in API manufacturing.
Novel patent CN105693737A describes efficient synthesis of chiral ligands. Offers supply chain stability and cost reduction for pharmaceutical manufacturing partners globally.
Patent CN101318146A reveals a novel organocatalyst enabling dual-handed synthesis of gamma-nitro ketones with high enantioselectivity, offering cost-effective solutions for API manufacturing.
Patent CN1842523A details a novel asymmetric hydrogenation process for enantiomerically pure beta-amino alcohols, offering significant cost reduction in API manufacturing.
Novel Grignard-based synthesis of L-nicotine offers cost reduction and scalability. Reliable supplier for pharmaceutical and agrochemical intermediates with stringent QC.
Patent CN1119332C details a novel asymmetric hydrogenation route for azepine intermediates, offering cost-effective and scalable production for kinase inhibitors like Balanol.